lisdexamfetamine dimesylate · Takeda Pharms Usa · NDA 021977, 208510
Vyvanse
Earliest generic entry, as listed · earliest of 13 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 13
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021977 · 001 · RLD | capsule, oral | 30MG | open |
| 021977 · 002 · RLD | capsule, oral | 50MG | open |
| 021977 · 003 · RLD | capsule, oral | 70MG | open |
| 021977 · 004 · RLD | capsule, oral | 20MG | open |
| 021977 · 005 · RLD | capsule, oral | 40MG | open |
| 021977 · 006 · RLD | capsule, oral | 60MG | open |
| 021977 · 007 · RLD | capsule, oral | 10MG | open |
| 208510 · 001 · RLD | tablet, chewable, oral | 10MG | open |
| 208510 · 002 · RLD | tablet, chewable, oral | 20MG | open |
| 208510 · 003 · RLD | tablet, chewable, oral | 30MG | open |
| 208510 · 004 · RLD | tablet, chewable, oral | 40MG | open |
| 208510 · 005 · RLD | tablet, chewable, oral | 50MG | open |
| 208510 · 006 · RLD | tablet, chewable, oral | 60MG | open |